Document Detail

Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.
MedLine Citation:
PMID:  23222419     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Hyperuricemia has been implicated in the development and progression of chronic kidney disease, both in animal experiments and in clinical studies. As a potentially modifiable risk factor, we examined whether serum uric acid levels correlate with early hypertension, kidney volume and progression to end-stage renal disease (ESRD) in autosomal-dominant polycystic kidney disease (ADPKD).
METHODS: Retrospective analysis of a prospective observational study of the natural history of ADPKD, conducted at the University of Colorado between 1985 and 2005. Included are 680 ADPKD adults who provided data on blood pressure, renal volume, renal function, uric acid, age at the onset of ESRD or last known age without ESRD. Serum uric acid levels were examined as a continuous variable and as gender-specific quartiles. The main outcome of interest was age at the onset of ESRD; secondary outcomes were hypertension onset before age 30 years and total kidney volume (TKV) at the study visit.
RESULTS: Subjects with early-onset hypertension had higher age-adjusted serum uric acid levels than those with no or late-onset hypertension despite similar creatinine clearance. After adjusting for age, gender and creatinine clearance, there was a 5.8% increase in TKV and 4.1% increase in TKV/body surface area for every 1 mg/dL increase in uric acid (P = 0.007). The multivariate-adjusted Cox regression demonstrated a greater hazard ratio for ESRD for subjects in the 4th and 3rd quartiles of uric acid compared with the 1st [4.8 (2.6-8.9; P < 0.001) and 2.9 (1.6-5.3; P < 0.001)].
CONCLUSIONS: Higher serum uric acid levels are associated with earlier onset of hypertension, larger kidney volume and increased hazard for ESRD in ADPKD independent of gender, body mass index and renal function at the study visit. Randomized interventional studies will be necessary to examine whether treating hyperuricemia has a protective role in ADPKD.
Imed Helal; Kim McFann; Berenice Reed; Xiang-Dong Yan; Robert W Schrier; Godela M Fick-Brosnahan
Related Documents :
9385439 - Identification of chlorella t-1 ingredient which enhances dmpo-oh adduct formation in f...
3901019 - Clinical implications of acetaldehyde adducts with hemoglobin.
7239699 - Induction of hypersensitivity reactions to lactobacillus fermentum and lipoteichoic aci...
17386529 - Dimethylthioarsinic anhydride: a standard for arsenic speciation.
7287639 - Fluorogenic reaction and specific microdetermination of ammonia.
17697979 - Novel transglucosylating reaction of sucrose phosphorylase to carboxylic compounds such...
15585759 - Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transc...
8308579 - Formula 18:2(n-6) and 18:3(n-3) content and ratio influence long-chain polyunsaturated ...
19538019 - Genotoxic and antibutyrylcholinesterasic activities of acid violet 7 and its biodegrada...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-12-04
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  28     ISSN:  1460-2385     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-02-15     Completed Date:  2013-08-30     Revised Date:  2014-02-04    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  380-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cohort Studies
Disease Progression*
Hypertension / epidemiology
Hyperuricemia / epidemiology
Kidney / pathology*
Kidney Failure, Chronic / epidemiology
Middle Aged
Organ Size
Polycystic Kidney, Autosomal Dominant / blood*,  complications,  pathology*
Prospective Studies
Regression Analysis
Retrospective Studies
Risk Factors
Uric Acid / blood*
Grant Support
Reg. No./Substance:
268B43MJ25/Uric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Factors associated with suboptimal initiation of dialysis despite early nephrologist referral.
Next Document:  Generation of mice derived from induced pluripotent stem cells.